Open-Label Exploratory Investigation of D-Cycloserine Augmentation to Cognitive Behavioral Therapy With Exposure and Response Prevention for Adults and Adolescents Diagnosed With Obsessive Compulsive Disorder - A Feasibility Study.
Phase of Trial: Phase II
Latest Information Update: 06 Feb 2014
At a glance
- Drugs Cycloserine (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 26 Dec 2013 Actual patient number (16) as reported by ClinicalTrials.gov record.
- 01 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Aug 2010 New trial record